A Double Blind Randomized Controlled of Placebo and Nebulized Lidocaine for Migraine Headache

Completed · Not applicable

Conditions studied: Migraine Headache

In brief

Migraine headaches have previously been shown to be responsive to intranasal lidocaine in a small study. Using a nebulizer to administer the drug would improve the feasibility of using the treatment. It would also spare the patient narcotics with their attendant side effects. Because of the potential for placebo effect a placebo control is necessary in this study.

Key facts

Study ID

NCT00287781

Run by

Kern Medical Center

People needed

150

Starts

2002-01-01

Expected to finish

2006-04-01

Last updated by the study team

2008-01-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Meets IHS criteria for migraine

You may not qualify if…

• Pregnant
• Breast feeding
• Allergic to Lidocaine
• Worst or first Headache
• Abnormal neurological exam
• Substance abuse within 6 months
• Cardiac, liver or pulmonary disease
• Participation n another study within 30 days

Where it is running

• Kern Medical Center — Bakersfield, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.